Characteristics, Diagnosis, and Management of Ehlers-Danlos Syndromes: A Review
- PMID: 29121166
- DOI: 10.1001/jamafacial.2017.0793
Characteristics, Diagnosis, and Management of Ehlers-Danlos Syndromes: A Review
Abstract
Importance: Ehlers-Danlos syndromes (EDSs) are a group of heritable connective tissue disorders. Patients with EDSs can develop excessive facial rhytids, nasal deformities, and facial scarring, for which they may seek consultation with a facial plastic surgeon. Ehlers-Danlos syndromes can be associated with serious surgical complications and should be identified preoperatively to facilitate optimal treatment. To our knowledge, no management guidelines for patients with EDSs exist in the facial plastic surgery literature. We present a review of the literature and management recommendations for the facial plastic surgeon.
Observations: We performed a PubMed/MEDLINE search for all publications in the English language related to surgical experience in patients with EDSs. A total of 37 publications (including reviews and case series) were included. Ehlers-Danlos syndromes are more common than appreciated, with an overall point prevalence between 1 in 2500 and 1 in 5000 according to existing literature. There are 6 main subtypes of EDSs that have significant phenotypic heterogeneity. Patients with classic type and hypermobile EDS (the 2 most common subtypes) can typically undergo elective facial plastic surgery without major complications. However, specific preoperative, intraoperative, and postoperative issues, as outlined in this review, must be taken into consideration. Vascular EDS should serve as a contraindication to elective surgery given its potential for life-threatening complications.
Conclusions and relevance: Because of their skin laxity, patients with EDSs may present more frequently to facial plastic surgeons' offices. Simple screening questions can help the surgeon identify potential patients with EDSs. Treatment should be individualized and performed with extreme care to ensure optimal outcomes.
Similar articles
-
Molecular genetic and clinical review of Ehlers-Danlos Type VIIA: implications for management by the plastic surgeon in a multidisciplinary setting.J Plast Reconstr Aesthet Surg. 2009 May;62(5):589-94. doi: 10.1016/j.bjps.2008.11.119. Epub 2009 Feb 23. J Plast Reconstr Aesthet Surg. 2009. PMID: 19233756 Review.
-
Cervicofacial rhytidoplasty in Ehlers-Danlos syndrome: hazards on healing.Plast Reconstr Surg. 1985 Jan;75(1):100-3. doi: 10.1097/00006534-198501000-00023. Plast Reconstr Surg. 1985. PMID: 3966088
-
Outcomes of orthopaedic surgery in Ehlers-Danlos syndromes: a scoping review.BMC Musculoskelet Disord. 2024 Oct 24;25(1):846. doi: 10.1186/s12891-024-07937-6. BMC Musculoskelet Disord. 2024. PMID: 39448975 Free PMC article.
-
Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines.Orphanet J Rare Dis. 2024 May 13;19(1):194. doi: 10.1186/s13023-024-03121-0. Orphanet J Rare Dis. 2024. PMID: 38741208 Free PMC article.
-
The Ehlers-Danlos syndromes, rare types.Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):70-115. doi: 10.1002/ajmg.c.31550. Am J Med Genet C Semin Med Genet. 2017. PMID: 28306225 Review.
Cited by
-
Patient and parent knowledge, understanding, and concerns after a new diagnosis of Ehlers Danlos syndrome.Orphanet J Rare Dis. 2024 Dec 30;19(1):493. doi: 10.1186/s13023-024-03517-y. Orphanet J Rare Dis. 2024. PMID: 39736684 Free PMC article.
-
Resource utilization and multidisciplinary care needs for patients with Ehlers-Danlos syndrome.Mol Genet Genomic Med. 2022 Nov;10(11):e2057. doi: 10.1002/mgg3.2057. Epub 2022 Sep 24. Mol Genet Genomic Med. 2022. PMID: 36151850 Free PMC article.
-
No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-Up.Cureus. 2023 Dec 11;15(12):e50346. doi: 10.7759/cureus.50346. eCollection 2023 Dec. Cureus. 2023. PMID: 38205452 Free PMC article.
-
Survey of Ehlers-Danlos Patients' ophthalmic surgery experiences.Mol Genet Genomic Med. 2020 Apr;8(4):e1155. doi: 10.1002/mgg3.1155. Epub 2020 Jan 27. Mol Genet Genomic Med. 2020. PMID: 31989797 Free PMC article.
-
Into the Tissues: Extracellular Matrix and Its Artificial Substitutes: Cell Signalling Mechanisms.Cells. 2022 Mar 7;11(5):914. doi: 10.3390/cells11050914. Cells. 2022. PMID: 35269536 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical